OSN New York and OSN New York Retina
OSN New York and OSN New York Retina
Source/Disclosures
Source:

Shamie N. The Light Adjustable Lens: Who are candidates and how does this new technology impact patient flow in the office? Presented at: OSN New York and OSN New York Retina; Oct. 17-18, 2020 (virtual meeting).

Disclosures: Shamie reports relevant financial disclosures with Allergan, Alcon, AMO, Avedro, Bausch + Lomb, CorneaGen, Glaukos, Ocular Therapeutix, Omeros, Oyster Point, Sun Pharma, TearLab, Visionary Ventures and Zeiss.
October 19, 2020
1 min read
Save

LAL allows office-based optimization after cataract surgery

Source/Disclosures
Source:

Shamie N. The Light Adjustable Lens: Who are candidates and how does this new technology impact patient flow in the office? Presented at: OSN New York and OSN New York Retina; Oct. 17-18, 2020 (virtual meeting).

Disclosures: Shamie reports relevant financial disclosures with Allergan, Alcon, AMO, Avedro, Bausch + Lomb, CorneaGen, Glaukos, Ocular Therapeutix, Omeros, Oyster Point, Sun Pharma, TearLab, Visionary Ventures and Zeiss.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Light Adjustable Lens gives patients the best uncorrected visual acuity at the distance of their choice and is a disruptive innovation in intraocular lens technology, according to a speaker here.

“Who is an ideal patient (for light adjustable lenses)? Anyone desiring uncorrected visual acuity at a distance of their choice and best uncorrected visual acuity. We are seeing visions of 20/20 and 20/15 even in patients who are post refractive," Neda Shamie, MD, Healio/OSN board member, said at the virtual OSN New York meeting.

The Light Adjustable Lens (RxSight) is the first FDA-approved light adjustable IOL, which allows for office-based optimization of vision after cataract surgery.

Good candidates for the lens include patients who desire the best uncorrected visual acuity at the distance of their choice, those with astigmatism up to 3 D and refractive lens exchange patients, according to Shamie.

Post-PRK, post-RK and post-LASIK patients are also good candidates for the Light Adjustable Lens.

Patients with dilated pupils less than 6.5 mm in size, those who are at risk of being noncompliant with postoperative UV protective glasses, and those who expect a full range of vision without glasses but are not interested in monovision are not good candidates for the technology, she said.

Two to 3 weeks postoperatively patients return to the office and undergo adjustments with a UV light projection system. The desired refraction and the current refraction is entered into the system and the patient undergoes a 40 second to 120 second procedure to adjust the lens to fine-tune their vision, she said.

To integrate the technology, practices must invest in the UV light projection system, plan to schedule for additional patient follow-up appointments and engage in outreach to the practice’s referring doctors, she said.

“The Light Adjustable Lens is an excellent option and a great addition to your surgical armamentarium. It really puts the practice on the map and gets the referring doctors, as well as patients and your staff, very excited about the advances you are offering to your patients. It’s truly a disruptive technology and one I hope you’d consider for your practice,” she said.